Compare LAD & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAD | BLCO |
|---|---|---|
| Founded | 1946 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.1B |
| IPO Year | 1996 | 2022 |
| Metric | LAD | BLCO |
|---|---|---|
| Price | $289.15 | $17.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | ★ $409.07 | $19.39 |
| AVG Volume (30 Days) | 329.1K | ★ 482.6K |
| Earning Date | 10-21-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ 9.01 | N/A |
| EPS | ★ 15.68 | N/A |
| Revenue | ★ $11,821,400,000.00 | $5,101,000,000.00 |
| Revenue This Year | $1.84 | $7.68 |
| Revenue Next Year | $3.26 | $5.95 |
| P/E Ratio | $17.41 | ★ N/A |
| Revenue Growth | ★ 17.20 | 6.47 |
| 52 Week Low | $239.78 | $14.44 |
| 52 Week High | $439.49 | $18.92 |
| Indicator | LAD | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 42.93 | 56.53 |
| Support Level | $278.92 | $16.71 |
| Resistance Level | $302.28 | $17.54 |
| Average True Range (ATR) | 14.30 | 0.52 |
| MACD | 1.57 | 0.07 |
| Stochastic Oscillator | 42.65 | 93.10 |
Lithia Motors is a retailer of new and used vehicles and related services. The company offers nearly 60 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US. We expect more deals over time in the US and, at times, abroad. Annual revenue in 2025 was $37.6 billion, and we see over $50 billion possible in a few years. The US was 78.5% of 2025 revenue and the UK second at 18.4%, due to the 2024 Pendragon acquisition. In 2025, new vehicle sales were about 50% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.